Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Astellas, Adaptimmune Hook Up on Off-the-Shelf Cell Therapies
January 15, 2020
-
REGULATORY Japan Likely to Take Pass on Rewarding Formulary Initiatives under Medical Fee Schedule
January 14, 2020
-
BUSINESS Meiji Gains Japan Rights for Novel Blood Cancer Treatment from HUYA Bioscience
January 10, 2020
-
BUSINESS Keytruda Top New Sales Generator in 2020, Enhertu Seen as Biggest Arrival: Evaluate
January 9, 2020
-
BUSINESS Daiichi Sankyo’s Blockbuster Hopeful Enhertu Hits US Market
January 8, 2020
-
ORGANIZATION As Off-Year Re-Pricing Looms, JPMA Chief Prods Govt to Minimize Product Coverage
January 7, 2020
-
REGULATORY MHLW to Set Up New Study Group on Detailing Activities Report System for All Medical Institutions
January 6, 2020
-
REGULATORY JETRO’s New York Office Gets First Health and Welfare Head in 2 Years
January 1, 2020
-
TRENDS 51 Drugs Listed in 2019 with Total Peak Sales Forecast of 370 Billion Yen, Many for Orphan Diseases
December 27, 2019
-
REGULATORY Councilor Mori Urges Drug Maker Management to Straighten Up as He Bids Farewell to MHLW
December 27, 2019
-
TRENDS Top 10 PHARMA JAPAN Articles in 2019
December 26, 2019
-
REGULATORY Japan's Global Health Confab to Prepare New Grand Design for Regulatory Harmonization in Asia
December 26, 2019
-
BUSINESS Opdivo/Yervoy Combo Filed for Frontline NSCLC in Japan
December 26, 2019
-
BUSINESS Kyowa Hakko Bio Hit with 18-Day Biz Suspension over GMP Failings
December 25, 2019
-
BUSINESS 15% Share Eyed for Jointly Developed Symbicort Generics, Toa Set to Push Uptake with Support App
December 25, 2019
-
BUSINESS Towa to Acquire Spanish Generic Player, Set to Venture into US/European Markets
December 24, 2019
-
BUSINESS Daiichi Sankyo, AZ Nab US Nod for ADC Enhertu in Breast Cancer
December 24, 2019
-
REGULATORY Fumi Yamamoto 1st Woman to Become MHLW’s Top Pharmacy Officer
December 23, 2019
-
REGULATORY Japan Approves Keytruda’s 1st Line RCC, Head and Neck Cancer Use, Bavencio’s Label Expansion and More
December 23, 2019
-
REGULATORY Japan Panel Hammers Out FY2020 Drug Pricing Reform
December 20, 2019
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…